Ignite Creation Date:
2025-12-25 @ 5:00 AM
Ignite Modification Date:
2026-01-28 @ 8:28 PM
Study NCT ID:
NCT00452218
Status:
COMPLETED
Last Update Posted:
2016-08-24
First Post:
2007-03-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
Sponsor:
University of Chicago
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
14636A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |